Creo Medical (GB:CREO) has released an update.
Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
Creo Medical Group has announced that directors Kevin Crofton and Richard Rees have purchased additional shares following recent fundraising efforts, with transactions carried out at 24 pence per share. This move highlights the leadership’s confidence in the company’s growth prospects, potentially attracting the attention of investors in the stock market.
For further insights into GB:CREO stock, check out TipRanks’ Stock Analysis page.
